Cibus, Inc.
Cibus, Inc. (CBUS) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · CBUS · as of Jun 9, 2026
Key Statistics
Explore Cibus, Inc. Data
cbus stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 4 · Buy rate: 75.0%
The CBUS analyst consensus is Buy, based on ratings from 4 Wall Street analysts over the past 3 months. The average 12-month price target is $11.50, representing +834.96% upside from the current price of $1.23.
Competitors & Peers
cbus competitorsCBUS
ACRV
BMEA
CAMP
IMUX
MNOVStock Performance
Full HistoryAbout Cibus, Inc.
Cibus, Inc. is an agricultural technology company dedicated to innovating and commercializing advanced plant characteristics. The firm's business model involves creating these beneficial traits and th…
what is cibus, inc. · cbus stock overview · cibus, inc. company profile · who is cibus, inc. ceo · cbus NASDAQ · cibus, inc. headquarters · cibus, inc. business segments
About Stock Overview & Key Data
Cibus, Inc. (CBUS) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jul 20, 2017. As of the latest trading session, CBUS stock price is $1.23, with a market capitalization of $55.9M. The stock has returned -25.45% over the past 12 months and -29.31% year-to-date.
According to 4 Wall Street analysts, the consensus rating for Cibus, Inc. stock is Buy, with an average 12-month price target of $11.50. In fiscal year 2025, Cibus, Inc. reported revenue of $3.6M and net income of -$127.1M. For detailed data — including Cibus, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Cibus, Inc. (CBUS) stock price is $1.23. The stock is traded on NASDAQ under the ticker symbol CBUS. The 52-week range is $1.09 – $4.19.